Genprex, Inc.

Other Events. On February 23, 2026, Genprex, Inc. (“Genprex” or the “Company”) issued a press release in which it announced that the Japanese Patent Office has

Other Events. On February 10, 2026, Genprex, Inc. (“Genprex” or the “Company”) issued a press release in which it announced that IP Australia, the Australian go

Other Events . On January 7, 2026, Genprex, Inc. (the “Company”) was formally notified (the “Compliance Notice”) that the Nasdaq Hearings Panel (the “Panel”) of

, including the information contained in Exhibit 99.1, is being furnished to the Securities and Exchange Commission, and shall not be deemed to be “filed” for t

Other Events. On January 6, 2026, Genprex, Inc. (“Genprex” or the “Company”) issued a press release announcing positive preliminary preclinical data from the st